Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A15278 | 28989564 | World J Hepatol | Diffusion weighted magnetic resonance imaging of liver: Principles, clinical applications and recent updates. | 2017 | Details |
| A15279 | 28989095 | J Hepatol | Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine. | 2017 | Details |
| A15280 | 28989092 | J Hepatol | Advanced liver fibrosis but not steatosis is independently associated with albuminuria in Chinese patients with type 2 diabetes. | 2017 | Details |
| A15281 | 28988798 | Free Radic Biol Med | Differential carbonylation of proteins in end-stage human fatty and nonfatty NASH. | 2017 | Details |
| A15282 | 28988228 | J Pediatr Endocrinol Metab | The relationship between non-alcoholic fatty liver disease and small intestinal bacterial overgrowth among overweight and obese children and adolescents. | 2017 | Details |
| A15283 | 28987868 | Redox Biol | Impairment of Akt activity by CYP2E1 mediated oxidative stress is involved in chronic ethanol-induced fatty liver. | 2017 | Details |
| A15284 | 28987323 | Pharmacol Ther | The longevity gene INDY (I'm Not Dead Yet) in metabolic control: Potential as pharmacological target. | 2017 | Details |
| A15285 | 28987260 | Clin Liver Dis | Treatment Strategies for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. | 2017 | Details |
| A15286 | 28986720 | Curr Atheroscler Rep | The Role of Metabolic Surgery in Non-alcoholic Steatohepatitis Improvement. | 2017 | Details |
| A15287 | 28986475 | Drug Metab Dispos | Pediatric Cytochrome P450 Activity Alterations in Nonalcoholic Steatohepatitis. | 2017 | Details |
| A15288 | 28986308 | Biochim Biophys Acta Mol Basis Dis | n-3 Fatty acids combined with flavan-3-ols prevent steatosis and liver injury in a murine model of NAFLD. | 2017 | Details |
| A15289 | 28985579 | Eur J Cancer | Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale. | 2017 | Details |
| A15290 | 28985395 | ILAR J | Nonhuman Primates and Translational Research-Cardiovascular Disease. | 2017 | Details |
| A15291 | 28983453 | Curr Pharmacol Rep | Remote Sensing between Liver and Intestine: Importance of Microbial Metabolites. | 2017 | Details |
| A15292 | 28983452 | Curr Pharmacol Rep | Role of FXR in Liver Inflammation during Nonalcoholic Steatohepatitis. | 2017 | Details |
| A15293 | 28982243 | J Agric Food Chem | Solanum nigrum Polyphenol Extracts Inhibit Hepatic Inflammation, Oxidative Stress, and Lipogenesis in High-Fat-Diet-Treated Mice. | 2017 | Details |
| A15294 | 28981521 | PLoS One | Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus. | 2017 | Details |
| A15295 | 28981167 | Acta Paediatr | Serum complement factor 5a levels are associated with nonalcoholic fatty liver disease in obese children. | 2017 | Details |
| A15296 | 28981157 | J Pineal Res | Effects of melatonin on fatty liver disease: The role of NR4A1/DNA-PKcs/p53 pathway, mitochondrial fission, and mitophagy. | 2017 | Details |
| A15297 | 28980219 | Curr Environ Health Rep | Persistent Endocrine-Disrupting Chemicals and Fatty Liver Disease. | 2017 | Details |
| A15298 | 28975595 | Indian J Gastroenterol | Risk factors for non-alcoholic fatty liver disease are common in patients with non-B non-C hepatocellular carcinoma in India. | 2017 | Details |
| A15299 | 28975533 | Indian J Gastroenterol | Association of single nucleotide polymorphism at PNPLA3 with fatty liver, steatohepatitis, and cirrhosis of liver. | 2017 | Details |
| A15300 | 28975492 | Obes Surg | Sleeve Gastrectomy Outcomes in Patients with BMI Between 30 and 35-3 Years of Follow-Up. | 2018 | Details |
| A15301 | 28974844 | Med Arch | Effects of Azilsartan, Aliskiren or their Combination on High Fat Diet-induced Non-alcoholic Liver Disease Model in Rats. | 2017 | Details |
| A15302 | 28973994 | Nutrients | Silibinin Restores NAD⁺ Levels and Induces the SIRT1/AMPK Pathway in Non-Alcoholic Fatty Liver. | 2017 | Details |
| A15303 | 28973659 | Toxicol Sci | Perfluorooctane Sulfonate-Induced Hepatic Steatosis in Male Sprague Dawley Rats Is Not Attenuated by Dietary Choline Supplementation. | 2017 | Details |
| A15304 | 28973532 | Toxicol Sci | Editor's Highlight: PCB126 Exposure Increases Risk for Peripheral Vascular Diseases in a Liver Injury Mouse Model. | 2017 | Details |
| A15305 | 28972878 | Discov Med | Role of nutrition, gene polymorphism, and gut microbiota in non-alcoholic fatty liver disease. | 2017 | Details |
| A15306 | 28972610 | Food Funct | fat-1 mice prevent high-fat plus high-sugar diet-induced non-alcoholic fatty liver disease. | 2017 | Details |
| A15307 | 28972537 | J Clin Invest | Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling. | 2017 | Details |
| A15308 | 28972487 | Georgian Med News | EFFECT THE CARDIOMETABOLIC RISK FACTORS ON VASCULAR AGING IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE CONCOMITANT WITH SUBCLINICAL HYPOTHYROIDISM. | 2017 | Details |
| A15309 | 28972485 | Georgian Med News | PECULIARITIES OF THE CLINICAL COURSE OF NON-ALCOHOLIC STEATOHEPATITIS AGAINST THE BACKGROUND OF THE CHRONIC KIDNEY DISEASE OF THE I-III STAGE WITH SECONDARY ARTERIAL HYPERTENSION. | 2017 | Details |
| A15310 | 28972119 | J Lipid Res | Loss of fatty acid binding protein-1 alters the hepatic endocannabinoid system response to a high-fat diet. | 2017 | Details |
| A15311 | 28971838 | Am J Physiol Gastrointest Liver Physiol | Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes. | 2017 | Details |
| A15312 | 28971098 | Front Nutr | The Nutraceutic Silybin Counteracts Excess Lipid Accumulation and Ongoing Oxidative Stress in an In Vitro Model of Non-Alcoholic Fatty Liver Disease Progression. | 2017 | Details |
| A15313 | 28970836 | Front Immunol | Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver Disease. | 2017 | Details |
| A15314 | 28970532 | Sci Rep | Blood-derived macrophages prone to accumulate lysosomal lipids trigger oxLDL-dependent murine hepatic inflammation. | 2017 | Details |
| A15315 | 28970254 | FASEB J | Silybin inhibits NLRP3 inflammasome assembly through the NAD+/SIRT2 pathway in mice with nonalcoholic fatty liver disease. | 2018 | Details |
| A15316 | 28970148 | Clin Gastroenterol Hepatol | Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis. | 2017 | Details |
| A15317 | 28970146 | Clin Gastroenterol Hepatol | Association Between Hepatic Steatosis, Measured by Controlled Attenuation Parameter, and Fibrosis Burden in Chronic Hepatitis B. | 2017 | Details |
| A15318 | 28970141 | Hum Pathol | Primary sclerosing cholangitis is protective against nonalcoholic fatty liver disease in inflammatory bowel disease. | 2017 | Details |
| A15319 | 28969511 | Stress | Interactive effects of chronic stress and a high-sucrose diet on nonalcoholic fatty liver in young adult male rats. | 2017 | Details |
| A15320 | 28968997 | Oncotarget | Dysregulated expression of proteins associated with ER stress, autophagy and apoptosis in tissues from nonalcoholic fatty liver disease. | 2017 | Details |
| A15321 | 28968053 | Practitioner | Improving the identification and monitoring of cirrhosis. | 2016 | Details |
| A15322 | 28967709 | ESC Heart Fail | Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction. | 2017 | Details |
| A15323 | 28966992 | Hepatol Commun | Hepatic Inositol 1,4,5 Trisphosphate Receptor Type 1 Mediates Fatty Liver. | 2016 | Details |
| A15325 | 28966079 | Trends Endocrinol Metab | Multifunctional p62 Effects Underlie Diverse Metabolic Diseases. | 2017 | Details |
| A15326 | 28965986 | Matrix Biol | Deficiency of periostin impairs liver regeneration in mice after partial hepatectomy. | 2017 | Details |
| A15327 | 28965313 | Obes Surg | Significant Liver-Related Morbidity After Bariatric Surgery and Its Reversal-a Case Series. | 2018 | Details |
| A15328 | 28965030 | J Nutr Biochem | Baked corn (Zea mays L.) and bean (Phaseolus vulgaris L.) snack consumption lowered serum lipids and differentiated liver gene expression in C57BL/6 mice fed a high-fat diet by inhibiting PPARγ and SREBF2. | 2017 | Details |
| A15329 | 28965028 | Diabetes Res Clin Pract | Angiopoietin-like protein 8: An attractive biomarker for the evaluation of subjects with insulin resistance and related disorders. | 2017 | Details |
| A15330 | 28964917 | Free Radic Biol Med | Redox imbalance due to the loss of mitochondrial NAD(P)-transhydrogenase markedly aggravates high fat diet-induced fatty liver disease in mice. | 2017 | Details |
| A15331 | 28964832 | Clin Chim Acta | NAFL screening score: A basic score identifying ultrasound-diagnosed non-alcoholic fatty liver. | 2017 | Details |
| A15332 | 28964678 | Dig Liver Dis | Fat accumulates preferentially in the right rather than the left liver lobe in non-diabetic subjects. | 2017 | Details |
| A15333 | 28964324 | Metabolism | Coffee consumption is not associated with prevalent subclinical cardiovascular disease (CVD) or the risk of CVD events, in nonalcoholic fatty liver disease: results from the multi-ethnic study of atherosclerosis. | 2017 | Details |
| A15334 | 28963767 | Liver Int | Body mass index trajectories in young adulthood predict non-alcoholic fatty liver disease in middle age: The CARDIA cohort study. | 2017 | Details |
| A15335 | 28962213 | Exp Ther Med | Effects of telmisartan on improving leptin resistance and inhibiting hepatic fibrosis in rats with non-alcoholic fatty liver disease. | 2017 | Details |
| A15336 | 31966406 | Int J Clin Exp Pathol | High incidence of non-alcoholic fatty liver disease in patients with Crohn's disease but not ulcerative colitis. | 2017 | Details |
| A15337 | 28961576 | J Clin Gastroenterol | Nonalcoholic Steatohepatitis is the Most Rapidly Increasing Indication for Liver Transplantation in Young Adults in the United States. | 2018 | Details |
| A15338 | 28960360 | Aliment Pharmacol Ther | Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease. | 2017 | Details |
| A15340 | 28956824 | Nutrients | Translational Aspects of Diet and Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A15341 | 28956816 | Nutrients | Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis. | 2017 | Details |
| A15342 | 28955967 | Biochem Biophys Rep | Quantitative imaging of fibrotic and morphological changes in liver of non-alcoholic steatohepatitis (NASH) model mice by second harmonic generation (SHG) and auto-fluorescence (AF) imaging using two-photon excitation microscopy (TPEM). | 2016 | Details |
| A15343 | 28955746 | Biochem Biophys Rep | Scaffold-free 3D bio-printed human liver tissue stably maintains metabolic functions useful for drug discovery. | 2017 | Details |
| A15344 | 28955124 | J Clin Biochem Nutr | Effects of soy isoflavone on hepatic steatosis in high fat-induced rats. | 2017 | Details |
| A15345 | 28955037 | Sci Rep | Human hepatic gene expression signature of non-alcoholic fatty liver disease progression, a meta-analysis. | 2017 | Details |
| A15346 | 28954437 | Nutrients | Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals. | 2017 | Details |
| A15347 | 28953935 | PLoS One | Association of MTTP gene variants with pediatric NAFLD: A candidate-gene-based analysis of single nucleotide variations in obese children. | 2017 | Details |
| A15348 | 28953675 | Medicine (Baltimore) | Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: A meta-analysis. | 2017 | Details |
| A15349 | 28953666 | Medicine (Baltimore) | Gender difference on the relationship between hyperuricemia and nonalcoholic fatty liver disease among Chinese: An observational study. | 2017 | Details |
| A15350 | 28953222 | Nutrients | Animal Models of Nonalcoholic Fatty Liver Disease-A Starter's Guide. | 2017 | Details |
| A15351 | 28952917 | Exp Clin Transplant | Accuracy of Noninvasive Fibrosis Scores in Predicting the Presence of Fibrosis in Patients after Liver Transplantation. | 2017 | Details |
| A15352 | 28951310 | Gene | Glucose regulated protein 78 is potentially an important player in the development of nonalcoholic steatohepatitis. | 2017 | Details |
| A15353 | 28951211 | Biochim Biophys Acta Mol Basis Dis | MicroRNA-194 inhibition improves dietary-induced non-alcoholic fatty liver disease in mice through targeting on FXR. | 2017 | Details |
| A15354 | 28950858 | Lipids Health Dis | Identification of deleterious rare variants in MTTP, PNPLA3, and TM6SF2 in Japanese males and association studies with NAFLD. | 2017 | Details |
| A15355 | 28948754 | Minerva Gastroenterol Dietol | Histopathology, grading and staging of nonalcoholic fatty liver disease. | 2017 | Details |
| A15356 | 28948665 | J Paediatr Child Health | Performance of fibrosis prediction scores in paediatric non-alcoholic fatty liver disease. | 2017 | Details |
| A15357 | 28948002 | Oncotarget | Linking atrial fibrillation with non-alcoholic fatty liver disease: potential common therapeutic targets. | 2017 | Details |
| A15358 | 28947922 | Clin Epigenetics | Diabetes medication associates with DNA methylation of metformin transporter genes in the human liver. | 2017 | Details |
| A15359 | 28947639 | J Investig Med | Influence of dietary macronutrients on liver fat accumulation and metabolism. | 2017 | Details |
| A15360 | 28947134 | J Formos Med Assoc | Elevated body mass index is a risk factor associated with possible liver cirrhosis across different etiologies of chronic liver disease. | 2017 | Details |
| A15361 | 28946547 | Cancer Biomark | Pioglitazone suppresses inflammation and fibrosis in nonalcoholic fatty liver disease by down-regulating PDGF and TIMP-2: Evidence from in vitro study. | 2017 | Details |
| A15363 | 28945101 | DNA Cell Biol | Implications of Sortilin in Lipid Metabolism and Lipid Disorder Diseases. | 2017 | Details |
| A15364 | 28944783 | Analyst | Changes induced by non-alcoholic fatty liver disease in liver sinusoidal endothelial cells and hepatocytes: spectroscopic imaging of single live cells at the subcellular level. | 2017 | Details |
| A15365 | 28944671 | J Proteome Res | Prioritizing Popular Proteins in Liver Cancer: Remodelling One-Carbon Metabolism. | 2017 | Details |
| A15366 | 28942551 | J Endocrinol Invest | Androgen excess and metabolic disorders in women with PCOS: beyond the body mass index. | 2017 | Details |
| A15367 | 28942443 | Cell Physiol Biochem | A Novel Role of SIRT1/ FGF-21 in Taurine Protection Against Cafeteria Diet-Induced Steatohepatitis in Rats. | 2017 | Details |
| A15368 | 28942436 | Horm Mol Biol Clin Investig | The color of fat and its central role in the development and progression of metabolic diseases. | 2017 | Details |
| A15369 | 28942246 | Free Radic Biol Med | Inhibition of hepatocyte nuclear factor 1b induces hepatic steatosis through DPP4/NOX1-mediated regulation of superoxide. | 2017 | Details |
| A15370 | 28941732 | Exp Mol Pathol | The adaptor protein alpha-syntrophin is reduced in human non-alcoholic steatohepatitis but is unchanged in hepatocellular carcinoma. | 2017 | Details |
| A15371 | 28941598 | Metabolism | Energy-matched moderate and high intensity exercise training improves nonalcoholic fatty liver disease risk independent of changes in body mass or abdominal adiposity - A randomized trial. | 2017 | Details |
| A15372 | 28941597 | Metabolism | Immunomodulatory liposomes targeting liver macrophages arrest progression of nonalcoholic steatohepatitis. | 2017 | Details |
| A15373 | 28941364 | Hepatology | Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year-community study. | 2018 | Details |
| A15374 | 28940752 | Mol Nutr Food Res | Supplementation with Docosahexaenoic Acid and Extra Virgin Olive Oil Prevents Liver Steatosis Induced by a High-Fat Diet in Mice through PPAR-α and Nrf2 Upregulation with Concomitant SREBP-1c and NF-kB Downregulation. | 2017 | Details |
| A15375 | 28940700 | Hepatology | Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis. | 2018 | Details |
| A15376 | 28939830 | Sci Rep | Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD. | 2017 | Details |
| A15377 | 28938561 | Oncotarget | Preventive effects of the sodium glucose cotransporter 2 inhibitor tofogliflozin on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic mice. | 2017 | Details |
| A15378 | 28938455 | J Clin Endocrinol Metab | Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects. | 2017 | Details |
| A15379 | 28937622 | Metabolites | Specificities of Human Hepatocellular Carcinoma Developed on Non-Alcoholic Fatty Liver Disease in Absence of Cirrhosis Revealed by Tissue Extracts ¹H-NMR Spectroscopy. | 2017 | Details |
| A15380 | 28937599 | Nutrients | Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease. | 2017 | Details |